Japan Pharmaceutical Manufacturers Association

Last updated

The Japan Pharmaceutical Manufacturers Association (JPMA) is the organization representing the research-based pharmaceutical industry operating in Japan.

The JPMA has 74 members including 20 overseas affiliates (as of October 1, 2006).

See also

Related Research Articles

Pharmaceutical Research and Manufacturers of America Trade group

Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA's stated mission is advocacy for public policies that encourage the discovery of new medicines for patients by companies engaged in pharmaceutical and biopharmaceutical research. Steve Ubl became PhRMA's chairman in September 2015. PhRMA is headquartered in Washington, DC.

Pharmaceutical industry Develops, produces, and markets drugs

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.

Manufacturing in Japan Overview of the manufacturing industry of Japan

Japan's major export industries include automobiles, consumer electronics, computers, semiconductors, copper, iron and steel.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth USD $110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a trade association that represents pharmaceutical companies around the world. It was formed in 1968 and is based in Geneva, Switzerland.

Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme

The Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) are two international instruments between countries and pharmaceutical inspection authorities. The PIC/S is meant as an instrument to improve co-operation in the field of Good Manufacturing Practices between regulatory authorities and the pharmaceutical industry.

European Federation of Pharmaceutical Industries and Associations

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association and lobbying organisation, founded in 1978 and representing the research-based pharmaceutical industry operating in Europe.

The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within the country. Manufacturers produce insulin, hormones, and cancer drugs. This sector provides 97% of the total medicinal requirement of the local market. The industry also exports medicines to global markets, including Europe. Pharmaceutical companies are expanding their business with the aim to expand the export market.

Good automated manufacturing practice (GAMP) is both a technical subcommittee of the International Society for Pharmaceutical Engineering (ISPE) and a set of guidelines for manufacturers and users of automated systems in the pharmaceutical industry. More specifically, the ISPE's guide The Good Automated Manufacturing Practice (GAMP) Guide for Validation of Automated Systems in Pharmaceutical Manufacture describes a set of principles and procedures that help ensure that pharmaceutical products have the required quality. One of the core principles of GAMP is that quality cannot be tested into a batch of product but must be built into each stage of the manufacturing process. As a result, GAMP covers all aspects of production; from the raw materials, facility and equipment to the training and hygiene of staff. Standard operating procedures (SOPs) are essential for processes that can affect the quality of the finished product.

Federation of Bangladesh Chambers of Commerce & Industries

Federation of Bangladesh Chambers of Commerce and Industries is the apex trade organization of Bangladesh playing a pivotal role in consultative and advisory capacity, safeguarding the interest of the private sector in the country.

Regal Lager, Inc. is a distributor of baby and children's products to both the United States and Canada, and is located in Kennesaw, Georgia. Regal Lager, Inc. works with companies outside the United States, and is known in the baby industry as a push-distributor as they not only provide distribution for their products, but marketing and advertising as well. They are best known for establishing the Baby Björn baby carrier brand in the United States throughout the 1990s. The company won The Swedish Trade Council's annual achievement award for Superb Consumer Market Adaptability in North America in 2001. Today Regal Lager, Inc. is currently responsible for the distribution of the Love To Dream, Dekor, Lascal, Qdos and Nomi brands.

The Juvenile Products Manufacturers Association, Inc. (JPMA) is a national trade organization that represents the juvenile industry defined as from prenatal to preschool. JPMA represents companies in the United States, Canada, and Mexico who manufacture, import and/or distribute infant products.

Taiho Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company, subsidiary of Otsuka Holdings. The company focuses on developing cancer treatments. Taiho is headquartered in Tokyo, Japan. Taiho is an R&D-driven specialty pharma focusing on the three fields of oncology, allergies and immunology, and urology.

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

Sumitomo Chemical

Sumitomo Chemical Co., Ltd. is a major Japanese chemical company. The company is listed on the first section of the Tokyo Stock Exchange and is a constituent of the on the Nikkei 225 stock index. It's a member of the Sumitomo group and was founded in 1913 as a fertilizer manufacturing plant.

The Association for Accessible Medicines (AAM), Washington, D.C., is a trade association representing the manufacturers and distributors of generic prescription drugs, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the U.S. generic drug industry. As the primary lobby for makers of generic drugs, AAM's stated mission is to advocate for public policies that facilitate timely access to lower-cost, FDA-approved generic and biosimilar medicines by consumers and patients. Over the 10-year period 2008 through 2018, the use of generic drugs generated $2 trillion in U.S. healthcare savings.

The Portuguese Pharmaceutical Industry Association is a trade association based in Lisbon. It was established in 1975, succeeding the National Guild of the Manufacturers of Medicinal Products.

Sanjay Kalra is an Indian endocrinologist working at Bharti Hospital, Karnal, Haryana. A graduate of Christian Medical College, Ludhiana, he completed his post-graduation (MD) in Medicine at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, and fellowship (DM) in Endocrinology and Metabolism at All India Institutes of Medical Sciences, New Delhi. Kalra is the Immediate Past President of Endocrine Society of India and Vice President of South Asian Federation of Endocrine Societies. He also serves on the executive council of the Research Society for Study of Diabetes in India. He has over 1000 PubMed indexed articles to his name, and has fostered bilateral and multilateral links between various Afro Asian countries in the field of endocrinology. He has developed the terms Glucocrinology and Lipocrinology. and the Gluco Coper tool to assess coping mechanisms. Winner of the DAWN Award (2009). He has also published the concepts of diabetes fatigue syndrome, euthymia in diabetes, quaternary prevention in endocrinology, and quinary prevention.